Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Testing EGFR with Idylla on Cytological Specimens of Lung Cancer: A Review.

International journal of molecular sciences - 3 May 2021

Caputo Alessandro, D'Ardia Angela, Sabbatino Francesco, Picariello Caterina, Ciaparrone Chiara, Zeppa Pio, D'Antonio Antonio

Abstract excerpt

The current standard of care for advanced non-small-cell lung cancer is based on detecting actionable mutations that can benefit from targeted therapy. Comprehensive genetic tests can have long turn-around times, and because EGFR mutations are the most prevalent actionable mutation, a quick detection would enable a prompt initiation of targeted therapy. Furthermore, the scarcity of diagnostic material means that...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Non-Small-Cell Lung
Share to DNA Mutational Analysis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to ErbB Receptors

Share to Genetic Testing

Share to Mutation

Share to Real-Time Polymerase Chain Reaction

Source

Open in PubMed Open full text

Identifiers

PMID: 34063720
DOI: 10.3390/ijms22094852
PMCID: PMC8125729

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Testing EGFR with Idylla on Cytological Specimens of Lung Cancer: A Review.PMID 34063720Read ↗

Feasibility of EGFR Mutation Testing Without Nucleic Acid Extraction in Scraped Cytologic Samples Using the Idylla Platform.Semantic proximity Read ↗

EGFR analysis: current evidence and future directions.Semantic proximity Read ↗

Idylla EGFR assay on extracted DNA: advantages, limits and place in molecular screening according to the latest guidelines for non-small-cell lung cancer (NSCLC) patients.Semantic proximity Read ↗

Use of the Idylla EGFR Mutation Test for Variant Detection in Non-Small Cell Lung Cancer Samples.Semantic proximity Read ↗

Not enough can be enough: feasibility of the Idylla EGFR mutation test when reuse of stained tissue slides is the only option available.Semantic proximity Read ↗

FNA smears as a potential source of DNA for targeted next-generation sequencing of lung adenocarcinomas.Semantic proximity Read ↗

Rapid EGFR evaluation from used H&E, IHC and FISH diagnostic slides with the Idylla platform.Semantic proximity Read ↗

Is the Idylla EGFR Mutation Assay feasible on archival stained cytological smears? A pilot studySemantic proximity Read ↗

<i>EGFR</i> mutation detection on lung cancer cytological specimens by the novel fully automated PCR-based Idylla <i>EGFR</i> Mutation AssaySemantic proximity Read ↗

Advanced non-small cell lung cancer: Rapid evaluation of EGFR status on fine-needle cytology samples using Idylla.Semantic proximity Read ↗

Liquid-based cytology specimens for next-generation sequencing in lung adenocarcinoma: challenges and evaluation of targeted therapy.Semantic proximity Read ↗

Cytology samples and molecular biomarker testing in lung cancer-advantages and challenges.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.